Northlane Capital Partners has announced it has invested in SAI MedPartners.
SAI, based in Reading, Pa., is a consultancy providing guidance and analytics to the pharmaceutical, biotechnology and medical device industries. Founded in 1978, the company has offices across the Americas, Europe, India and Asia.
NCP, based in Bethesda, Md., is a middle…
RoundTable Healthcare Partners has announced it has completed a majority investment into Polymedco.
Polymedco, based in Cortlandt Manor, N.Y., is a marketer and distributor of diagnostic tests primarily used for colorectal cancer screening and the diagnosis of cardiac conditions. Founded in 1980, the company’s products are sold to distributors, hospital systems, payors and laboratories…
The Supreme Court (Court) will soon decide whether to take up a critical (and long-running) issue concerning applicability of Federal Rule of Civil Procedure 9(b) pleading standards in False Claim Act (FCA) suits. To satisfy Rule 9(b)’s particularity requirement for fraud allegations, FCA plaintiffs generally have needed to detail specific false claims submitted by defendants. The question that has divided federal courts for more than a decade is whether a plaintiff instead may plead the submission of false claims more generally without identifying specific claims if they provide sufficient reliable indicia that false claims were submitted—such as the qui tam plaintiff’s personal knowledge of or participation in the alleged fraudulent practices that are the basis of the FCA action. The issue is particularly salient in cases where the government declines intervention and the whistleblower (or relator), who is often a former employee of the defendant, may not have access to the relevant invoices at issue.[1]
Frazier Healthcare Partners has announced the acquisition of Apollo Intelligence.
Apollo, based in Watertown, Mass., is a provider of data and insights to the healthcare and life science industries. Apollo launched in 2019 with the acquisition of InCrowd, a provider of automated insights for the life sciences. In 2020, the company acquired Survey Healthcare Global,…
On June 3, 2022, the Financial Crimes Enforcement Network (FinCen) issued an Advance Notice of Proposed Rulemaking proposing public comment on the enactment of a no-action letter process. This Advanced Notice follows FinCen’s Report to Congress submitted in June 2021 that was based on FinCen’s consultation with the Attorney General, State bank supervisors, State credit union supervisors, and other Federal agencies and regulators. In its report, FinCen evaluated the difficulties it faces because of the overlap between its enforcement authority and other regulators. FinCen also examined the benefits and concerns on how a no-action letter process could affect illicit finance risks. FinCen stated that the primary benefits of a no-action letter process “are that it could promote a robust and productive dialogue with the public, spur innovation among financial institutions, and enhance the culture of compliance and transparency in the application and enforcement of BSA.” Ultimately, FinCen concluded that it should establish a rulemaking to create a no-action letter process.
Sheridan Capital Partners has announced the sale of Dermatologists of Central States (DOCS) to SkyKnight Capital.
DOCS, headquartered in Cincinnati, is a provider of management services to dermatology practices in the Midwest and Southeast United States. The organization has a presence in seven states: Illinois, Indiana, Michigan, North Carolina, Ohio, Pennsylvania and West Virginia.…
FFL Partners has announced it has closed its fifth fund, FFL Capital Partners V, with more than $900 million in total capital commitments.
The fund was oversubscribed, exceeding its initial target of $750 million.
FFL Partners, based in San Francisco, invests in middle market companies within healthcare and business services. Founded in 1997, the…
In 2021, the Health Information Technology for Economic and Clinical Health Act (HITECH) was amended to add “recognized cybersecurity practices” as a mitigating factor when determining fines, audits and remedies against covered entities and business associates for violations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). The Department of Health and Human…
An affiliate of EW Healthcare Partners will acquire TherapeuticsMD, according to a news release.
TherapeuticsMD, based in Boca Raton, Fla., and traded on the NASDAQ under TXMD, develops and commercializes products exclusively for women. Founded in 1907, the company’s products have a therapeutic focus in family planning, reproductive health and menopause management.
EW…
On May 25, the Federal Trade Commission announced that it, along with the Department of Justice, fined Twitter $150 million for violating a 2011 agreement with the FTC in which Twitter promised to protect the integrity of nonpublic consumer information, including users’ phone numbers and email addresses.
Read on for details about the alleged violations…
